ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
AMGN C 0.84 8.14
GILD C 0.14 7.41
VRTX F 1.46 7.21
BIIB D 0.92 6.12
ILMN D -0.09 5.67
REGN D -0.25 4.13
ALXN B 0.35 3.02
SGEN F -1.12 2.25
INCY F -1.08 2.09
BMRN F -1.48 1.91
ALNY F -3.00 1.60
VTRS F 0.79 1.35
SNY B 0.75 1.29
NBIX F 0.71 1.16
SRPT F -1.29 1.15
NVCR D -0.32 1.10
JAZZ C 0.29 1.03
TECH A 0.88 1.02
IONS F -0.77 1.02
GH B -1.47 0.96
HZNP B 0.53 0.87
AMRN D -1.17 0.85
MRNA D 5.26 0.83
BGNE D -2.02 0.83
ACAD F -1.40 0.81
PRAH A -0.19 0.81
SYNH A 1.71 0.80
ASND F -3.01 0.77
EXEL B -1.03 0.73
RETA F -6.80 0.70
ARWR D -2.45 0.65
BLUE F -2.46 0.65
GBT F -1.09 0.61
CBPO C -0.24 0.54
BBIO D -6.25 0.51
ALLK D -2.78 0.49
UTHR A 1.31 0.49
NKTR F -3.17 0.48
SAGE D -0.69 0.48
BPMC D 0.09 0.48
FGEN F -1.28 0.47
MRTX F 1.84 0.46
DCPH F -1.35 0.43
AGIO B -0.28 0.43
CRSP F -3.85 0.42
RARE F -2.88 0.42
ICPT F -5.01 0.42
ADPT F -3.88 0.42
GWPH A -0.03 0.42
MEDP B 1.70 0.40
PTCT F -1.37 0.40
ARGX D -1.09 0.40
AXSM F -2.03 0.38
ALLO F -2.47 0.37
XLRN C -1.91 0.36
GRFS B 1.81 0.36
IOVA F -3.58 0.36
ALKS D -0.16 0.36
KOD D -1.09 0.35
HALO D 1.35 0.35
QURE F -4.90 0.35
KRTX C -0.87 0.33
FOLD F -0.86 0.32
CCXI F 0.59 0.31
APLS D 0.02 0.31
EPZM F -0.59 0.31
ZGNX F -0.93 0.29
ARNA F -0.30 0.28
XNCR F -2.83 0.26
MYGN C -1.12 0.26
DNLI D -1.38 0.26
TPTX F -3.79 0.26
EIDX C 0.00 0.25
ZLAB D -0.19 0.24
IRWD D -1.45 0.24
ARVN D -1.46 0.24
INSM F -1.92 0.23
FATE D -1.29 0.23
PCRX D -0.36 0.22
GLPG F -0.10 0.22
ITCI D 0.57 0.21
TCDA F 2.83 0.21
RGNX F -0.03 0.21
ESPR F -4.50 0.19
EDIT F -3.19 0.19
LGND D -1.41 0.19
INVA D -1.56 0.18
DRNA D -1.25 0.18
VCYT D -1.50 0.18
ALEC F -11.51 0.18
TBPH B -3.77 0.17
YMAB F -7.41 0.16
CHRS F -1.06 0.16
HCM F 2.31 0.15
NGM D -3.67 0.15
SUPN C 0.71 0.15

Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

Date Stock Title
Apr 11 BPMC Blueprint Medicines Data Highlight Clinical Leadership in Systemic Mastocytosis at AACR Annual Meeting 2021
Apr 11 TECH How Google Invented Technological Dystopia with Project Bernanke
Apr 11 REGN 4 Undervalued Stocks To Watch For In April
Apr 11 ALNY Alnylam Presents Positive Late-Breaking Data from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension
Apr 11 IONS 3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
Apr 11 VRTX 3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
Apr 11 BLUE TUESDAY DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages bluebird bio, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUE
Apr 11 GWPH Healthcare Investors: Here's What You Need to Know About Medical Marijuana
Apr 10 MRTX Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models
Apr 10 TECH Why Alibaba Just Got Hit With A Record $2.87 Billion Fine In China
Apr 10 TECH Bio-Techne: Stealth M&A Play Looking Rich Here
Apr 10 MRTX The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 FGEN The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 BPMC The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 BGNE The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 ACAD The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 GH Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
Apr 10 CRSP CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
Apr 10 ALLO Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
Apr 10 BPMC Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Nasdaq Industry Classification Nasdaq Biotech Nasdaq Biotechnology Index Nasdaq Biotechnology Total Return Index
Back to the Main BIS Page...